Telehealth: Déjà vu all over again?
October 6, 2020The COVID-19 pandemic has made telehealth the undeniable centerpiece of our healthcare system in fewer than ten months.
Read PostWhat is the “New Normal” for Medical Residents?
November 9, 2020COVID-19 has upended virtually every aspect of healthcare, including medical education. As the novel coronavirus expanded from a crisis to a pandemic, medical students adjusted to online learning from home. Residents and fellows were told to avoid direct patient care, got pulled into ERs and ICUs to treat COVID-19 patients, or saw clinical rotations canceled altogether.
Preparing for the Fall 2021 CV Board Exam: 6 Ways to Map Your Strategy
October 1, 2020Did you opt to postpone sitting for the ABIM CVB exam until October 2021? No matter what factors contributed to your decision, you now have the power to approach your exam preparation as more of a marathon than a sprint.
K2P Recognizes Women in Medicine
September 15, 2020Each September, the American Medical Association (AMA) celebrates Women in Medicine (WIM) Month. The observance is intended to highlight the many accomplishments of women physicians and to increase advocacy related to women physicians and to the health care of women patients.
Rethinking Rhythm Control in AF: Sooner Rather than Later?
September 8, 2020One of the several noteworthy trials presented at the virtual ESC Congress was the EAST-AFNET 4NET 4 trial, which was published concurrently in the New England Journal of Medicine.
Evidence and Hope During the Pandemic
September 2, 2020Encouraging results were published today, September 2, in JAMA reporting on the reduction in 28-day mortality associated with steroid administration in critically ill COVID-19 patients. The authors reported on their prospective meta-analysis of 7 randomized trials, with a total of 1703 patients, who were randomized to either corticosteroids or placebo (or usual care). There were
Early News from the Virtual ESC Congress EXPLORER-HM
August 31, 2020Lacopo Olivotto, MD, presented the results of the EXPLORER-HCM trial, which examined mavacamten as an alternative to surgical or catheter-based interventions to treat obstructive hypertrophic cardiomyopathy (HCM).
Tips to Address the Challenges of non-COVID Care in the Time of a Pandemic
August 10, 2020In addition to managing the enormous burden of COVID-19 infection and mortality, clinicians are also charged with how we can best provide ongoing regular care for non-COVID patients.
COVID-19: Impact on Cardiovascular Disease Care, Lifelong Learning, and Research
July 27, 2020In a special report last week, the European Heart Journal spoke to cardiovascular disease (CVD) thought leaders across the globe to gather their insights on the impact of the COVID-19 pandemic on cardiovascular care.
Virtual Care: Time to Develop Your “Screenside” Manner?
July 22, 2020Various healthcare organizations are working to better prepare physicians and advanced practice providers for best practices in providing virtual care.
Post-COVID-19: A New and Improved Normal?
July 14, 2020The pandemic has accelerated the pace of positive change, exposed longstanding racial inequalities that resulted in a disproportionate burden of COVID-19 infection and mortality, and demonstrated new learning needs for health care professionals.
Dexamethasone in the Treatment of COVID-19
June 16, 2020THE RECOVERY TRIAL News emerged from the UK on June 16 around very promising results with dexamethasone in the treatment of COVID-19 infected patients in the Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial. RECOVERY is a randomized trial investigating whether treatment with either (1)Lopinavir-Ritonavir, (2)Hydroxychloroquine, (3)Corticosteroids, (4)Azithromycin,(5) Convalescent plasma or (6)Tocilizumab prevents death in patients with COVID-19.
The Endothelium: A Common Denominator Underlying “Atypical” Manifestations of COVID-19?
June 15, 2020A group of Italian researchers recently hypothesized that it is actually the endothelium that is being targeted by the COVID-19 virus.